Antonella Capozza

Antonella Capozza

Auto-generated profile, based on publicly available information

Antonella Capozza

Unit of Nuclear Medicine, ASST Santi Paolo e Carlo, Milan, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
ABAlberto Bestetti
Alberto Bestetti
ACAntonella Capozza
Antonella Capozza
MLMarco Lacerenza
Marco Lacerenza
LMLuigi Manfredi
Luigi Manfredi
FMFrancesca Mancini
Francesca Mancini
Gastrointestinal dysfunction is often described in patients with Parkinson disease (PD), and gastrointestinal symptoms are usually attributed to gastroparesis. The consequent delayed gastric emptying (GE) may be an important pharmacokinetic mechanism underlying some of the response fluctuations that develop after long-term levodopa (L-dopa) therapy.The aim of this prospective study was to assess GE time by a liquid meal scintigraphy, in PD patients, and to correlate them with demographic, clinical, and therapeutic data. Scintigraphy with radiolabeled albumin nanocolloids added to acidified orange juice was performed in 51 consecutive PD patients 1 hour after their usual dopaminergic therapy first dose and after a 12-hour fast. Demographic, neurologic, gastrointestinal, and pharmacologic data were collected. Fifty-one patients were divided into 2 groups using the cutoff point obtained in normal subjects (40 minutes): group 1 included 29 patients with GE T½ of 27.60 ± 7.30 minutes (normal), group 2 showed a GE T½ of 84.90 ± 53.80 minutes (delayed). The most striking significant difference between the 2 groups was the dopa-decarboxylase inhibitor mean dose that was significantly higher in the group of patients with delayed GE (201.32 ± 97.26 vs 127.65 ± 79.74; P = 0.005). The impairment of gastric motility, frequently represented in PD patients, occurs in approximately 42% of patients with motor complications. A mechanism that may explain the GE delay is the effect of L-dopa on dopaminergic receptors in the stomach. Therefore, the dosage of dopa-decarboxylase inhibitor, increasing the L-dopa concentration, may contribute to GE delay and its consequent effect on drug delivery and efficacy.

1 May 2018 in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
LTLuca Tagliabue
Luca Tagliabue
ACAntonella Capozza
Antonella Capozza
CMClaudio Maioli
Claudio Maioli
ALAndrea Luciani
Andrea Luciani
AIAnna M. Ierardi
Anna M. Ierardi
GCGianpaolo Carrafiello
Gianpaolo Carrafiello
Article: Immunotherapy treatment: an issue for metabolic response - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 June;62(2):140-51 - Minerva Medica - Journals

26 May 2026 in Neurology
Verified
Journal Article
Open access
PDF file
BSBenedetta Storti
Benedetta Storti
ACAntonella Capozza
Antonella Capozza
GMGiulia Marinoni
Giulia Marinoni
CSCamilla Strazzabosco
Camilla Strazzabosco
MSMario Stanziano
Mario Stanziano
Anna BersanoAnna Bersano
Anna Bersano
Background and ObjectivesIatrogenic cerebral amyloid angiopathy (iCAA) is a rare form of CAA believed to result from β-amyloid (Aβ) transmission during neurosurgical procedures. We aimed to compare...

1 January 2016 in Heart International
Verified
Journal Article
Open access
ABAlberto Bestetti
Alberto Bestetti
ACAntonella Capozza
Antonella Capozza
SMSimona Malaspina
Simona Malaspina
FLFrancesco Laudicina
Francesco Laudicina
MGMaurizio Gallieni
Maurizio Gallieni
PurposeCardiac screening in adult kidney transplant candidates with myocardial perfusion scintigraphy (MPS) can reveal findings associated with increased risk for coronary heart disease events, but the exact value of this screening test is still undetermined.MethodsNarrative review based on the available literature and guidelines on the yield, benefits, and harms of MPS screening in kidney transplant candidates.ResultsAlthough coronary angiography carries low risk in general population, it is not without risk particularly in patients with complex comorbid disease and the use of intravenous contrast media may precipitate a need for hospitalization and death. We could avoid invasive coronary angiography in patients with chronic kidney disease, although with high coronary calcium score, but good left ventricle function and normal perfusion, evaluated by Gated single-photon emission computed tomographic (SPECT) MPS. In fact, although Gated SPECT MPS has not a high sensitivity, it provides some variables that are closely related to sudden death: post-stress and rest-ejection fraction and left ventricular volumes, left ventricle muscle mass, extent of ischemia and scar.ConclusionsGated SPECT MPS is a valid noninvasive cardiac screening test. It can be used as alternative to stress echocardiography in kidney transplant candidates with high cardiovascular risk and a positive or inconclusive exercise tolerance ECG test.Patients with abnormal perfusion and cardiac dysfunction should undergo invasive coronary artery imaging and endovascular treatment, while angiography could be avoided in patients with normal MPI, having good long-term prognosis